|
Volumn 176, Issue 7, 2002, Pages 332-334
|
The road to consensus: Considerations for the safe use and prescribing of COX-2-specific inhibitors
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOOXYGENASE 2 INHIBITOR;
NONSTEROID ANTIINFLAMMATORY AGENT;
ARTICLE;
AUSTRALIA;
DATA ANALYSIS;
DRUG SAFETY;
DRUG USE;
EVIDENCE BASED MEDICINE;
FOOD AND DRUG ADMINISTRATION;
GENERAL PRACTICE;
MEDICAL EDUCATION;
PRACTICE GUIDELINE;
PRESCRIPTION;
RHEUMATIC DISEASE;
CONSENSUS DEVELOPMENT CONFERENCES;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DATA INTERPRETATION, STATISTICAL;
EVIDENCE-BASED MEDICINE;
HUMANS;
ISOENZYMES;
MEMBRANE PROTEINS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
|
EID: 0036531077
PISSN: 0025729X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (10)
|
References (14)
|